Skip to main content

Pfizer claims 3rd dose 'strongly' boosts protection against Delta variant

Share

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the Delta variant -- beyond the protection afforded by the standard two doses, suggests new data released by Pfizer on Wednesday.

The data posted online, which are expected to be discussed in a company earnings call on Wednesday morning, suggest that antibody levels against the Delta variant in people ages 18 to 55 who receive a third dose of vaccine are greater than five-fold than following a second dose.

Among people ages 65 to 85, the Pfizer data suggest that antibody levels against the Delta variant after receiving a third dose of vaccine are greater than 11-fold than following a second dose.

There's "estimated potential for up to 100-fold increase in Delta neutralization post-dose three compared to pre-dose three," researchers wrote in the Pfizer data slides.

The data have not yet been peer-reviewed or published.

The data also show that antibody levels are much higher after a third dose than a second dose against the original coronavirus variant and the Beta variant, first identified in South Africa.

CTVNews.ca Top Stories

New weight-loss drug Wegovy not a 'magic bullet,' doctor warns

As Wegovy becomes available to Canadians starting Monday, a medical expert is cautioning patients wanting to use the drug to lose weight that no medication is a ''magic bullet,' and the new medication is meant particularly for people who meet certain criteria related to obesity and weight.

Drew Carey is never quitting 'The Price Is Right'

Drew Carey took over as host of 'The Price Is Right' and hopes he’s there for life. 'I'm not going anywhere,' he told 'Entertainment Tonight' of the job he took over from longtime host Bob Barker in 2007.

Local Spotlight

Stay Connected